Partnerships
Building Stronger Collaborations for a Healthier Future
At LunaVax, we believe that partnerships are essential to transforming vaccine accessibility and global health equity. By working closely with health organizations, research institutions, mission-driven foundations, governments, and private sector leaders, we accelerate vaccine development, strengthen supply chains, and expand immunization programs across Africa.
How We Work With Partners
1. LunaVax Collaboratives
We team up with global health leaders, research institutions, and mission-aligned partners to accelerate vaccine innovation, scale local production, and expand access to life-saving immunizations. Through joint research, technology transfer, and funding, LunaVax collaboratives advance next-generation platforms including mRNA, self-amplifying RNA (saRNA), protein subunit, viral vector, DNA-based vaccines, and microneedle patches, tailored to Africa’s unique health needs.
2. Tech Partnerships
We partner with logistics innovators, drone tech providers, mobile health tech manufacturers, and AI-powered supply chain partners to expand last-mile vaccine delivery. LunaVax uses a hybrid model combining drone-powered drops, biometric verification, cold-chain systems, and real-time data reporting to bring vaccines directly to overlooked communities regardless of location or infrastructure.
3. Research & Development
We work with biomedical scientists and research institutions to co-create vaccine solutions tailored to Africa’s health needs. Our R&D focuses on next-generation platforms including mRNA, saRNA, protein subunit, viral vector, and DNA-based vaccines, while pioneering microneedle patches and biometric tools for patient tracking. These breakthroughs ensure our immunization programs stay scalable, accurate, and data-driven, from lab to last mile.
4. Community Engagement & Awareness
We engage with governments, NGOs, and local health agencies to boost vaccine awareness, reduce hesitancy, and strengthen last-mile infrastructure. Our advocacy efforts center on education, community trust, and digital health innovations, ensuring underserved populations receive timely, equitable immunization.